Following concerns about whether side effects of ranitidine in Zantac increase the risk of cancer, the U.S. Food and Drug Administration (FDA) announced that all ranitidine-based drugs should be removed from the market, including name-brand Zantac, over-the-counter and all generic equivalents. (more…) Read More
Independent testing by an online pharmacy confirmed that users of Zantac may have been exposed to high levels of the human carcinogen N-Nitrosodimethylamine (NDMA). These findings led to nationwide calls for a Zantac recall and lawsuits against drug manufacturers for failing to adequately warn about the… Read More
Following an alarming discovery announced by the FDA, the lawyers at Saiontz & Kirk, P.A. began investigating the potential for Zantac lawsuits after the known human carcinogen N-Nitrosodimethylamine (NDMA) was detected in the widely used heartburn drug. At the time, our firm also represented individuals nationwide… Read More
